Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

NCT04715022 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Cardiovascular Diseases

Interventions

DRUG: Ascorbic acid solution (American Regent Laboratories Inc.)
DRUG: Saline

Sponsor

University of Kansas Medical Center